GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Accounts Payable & Accrued Expense

Immunoclin (Immunoclin) Accounts Payable & Accrued Expense : $2.10 Mil (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Accounts Payable & Accrued Expense?

Immunoclin's quarterly accounts payable & accrued expense increased from Apr. 2014 ($1.15 Mil) to Jul. 2014 ($1.78 Mil) and increased from Jul. 2014 ($1.78 Mil) to Oct. 2014 ($2.10 Mil).

Immunoclin's annual accounts payable & accrued expense increased from Feb. 2012 ($0.09 Mil) to Jan. 2013 ($0.51 Mil) and increased from Jan. 2013 ($0.51 Mil) to Jan. 2014 ($0.73 Mil).


Immunoclin Accounts Payable & Accrued Expense Historical Data

The historical data trend for Immunoclin's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Accounts Payable & Accrued Expense Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Accounts Payable & Accrued Expense
0.09 0.51 0.73

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 1.15 1.78 2.10

Immunoclin Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Immunoclin (Immunoclin) Business Description

Industry
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines